273
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Nanostructured lipid carrier for transdermal gliclazide delivery: development and optimization by Box-Behnken design

, ORCID Icon, , , , & show all
Received 07 Apr 2021, Accepted 25 Nov 2021, Published online: 10 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (3)

Ramankit Jaiswal & Rita Wadetwar. (2023) Nanostructured lipid carriers mediated transdermal delivery of trandolapril as an impeccable therapeutic approach against hypertension: Development, characterization and in vivo evaluation. OpenNano 11, pages 100144.
Crossref
Alhussain H. Aodah, Sana Hashmi, Naseem Akhtar, Zabih Ullah, Ameeduzzafar Zafar, Randa Mohammed Zaki, Shamshir Khan, Mohammad Javed Ansari, Talha Jawaid, Aftab Alam & Md Sajid Ali. (2023) Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections. Gels 9:4, pages 322.
Crossref
Muhammad Ibrahim, Shehla Munir, Sarfraz Ahmed, Adeel Hussain Chughtai, Waqas Ahmad, Jallat Khan, Mogana Das Murtey, Hira Ijaz & Suvash Chandra Ojha. (2022) Gliclazide in Binary and Ternary Systems Improves Physicochemical Properties, Bioactivity, and Antioxidant Activity. Oxidative Medicine and Cellular Longevity 2022, pages 1-20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.